Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Claire Long

- PMLiVE

Moderna’s RSV vaccine mRESVIA granted FDA approval for use in older adults

The approval marks the first time an mRNA vaccine has been approved for a disease other than COVID-19

- PMLiVE

Pfizer shares positive five-year results for Lorbrena in advanced lung cancer

The majority of Lorbrena-treated patients were alive without disease progression after five years

- PMLiVE

There is nothing as constant as change

Creating the right mindset – the three main responses to change

- PMLiVE

Improving outcomes through increased patient education

By Abi Bowden

- PMLiVE

Pioneering a sustainable future in healthcare communications

By Rhiannon Meaden

- PMLiVE

Sustainable Meetings Best Practices Infographic

Learn how virtual meetings reduce environmental impact and save costs while maintaining high-quality engagement. Perfect for professionals seeking eco-friendly solutions.

Impetus Digital

- PMLiVE

Medscape Education to Emphasize the Role of Education in Digital Therapeutics at DTA Summit

As a leader in medical education and proud sponsor of the 2024 Digital Therapeutics Summit, Medscape is excited to announce that Medscape Education’s Chief Strategy Officer, Christina Hoffman, will be...

Medscape Education Global

- PMLiVE

Medscape Oncology to Make a Significant Impact at ASCO 2024

ASCO is one of the biggest conferences of the year for Medscape Oncology, and the team is ready to make an impact in Chicago. They’ll be manning booth #26030, where...

Medscape Education Global

Biogen Idec building

Biogen’s Qalsody granted EC approval to treat rare form of ALS in adults

Mutations in the SOD1 gene are responsible for an estimated 2% of all ALS cases

- PMLiVE

Merck to expand ophthalmology pipeline with acquisition of EyeBio in deal worth up to $3bn

Merck will gain access to EyeBio’s Restoret to prevent and treat retinal vascular leakage-associated vision loss

- PMLiVE

Bristol Myers Squibb’s Opdivo approved by EC for adults with urothelial carcinoma

UC accounts for approximately 90% of all bladder cancers, the ninth most common cancer globally

- PMLiVE

Sanofi/Regeneron’s Dupixent recommended by CHMP for uncontrolled COPD

No new treatment approaches have been approved for the respiratory disease in more than a decade

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links